01-06-2014 | Original Article
Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumors
Published in: Cancer Chemotherapy and Pharmacology | Issue 6/2014
Login to get access